AI for Health

 

Onsite Expert Jury Members

 
Pedro Castel-Branco
Armilar Venture Partners

Pedro Castel-Branco

Armilar Venture Partners (Portugal)
Virtual care
Drug discovery
prevention
Mathieu Chaffard
Mathieu Chaffard

Mathieu Chaffard

Roche Diagnostics International (Switzerland)
Virtual care
Drug discovery
prevention
Fabrizio Conicella
Chiesi Farmaceutici

Fabrizio Conicella

head Open Innovation & Competence
Chiesi Farmaceutici (Italy)
Virtual care
Antoine D'Hollander
Capricorn Partners

Antoine D'Hollander

Investment Manager
Capricorn Partners (Belgium)
Virtual care
prevention
Coenraad Davidsdochter
Qserve Group

Coenraad Davidsdochter

Senior Consultant
Qserve Group (Netherlands)
Virtual care
prevention
Jana Drechsler
EWG - Essener Wirtschaftsförderung

Jana Drechsler

Project Management Healthcare
EWG - Essener Wirtschaftsförderung (Germany)
Virtual care
Jan Engels
High-Tech Gruenderfonds (HTGF)

Jan Engels

Investment Manager
High-Tech Gruenderfonds (HTGF) (Germany)
Virtual care
Drug discovery
prevention
Nicolas Guggenheim
-

Nicolas Guggenheim

Independent Board Member and Strategic Investor in Healthcare
- (Switzerland)
Virtual care
Tyler Hayes
Thuja Capital

Tyler Hayes

Principal
Thuja Capital (Netherlands)
Drug discovery
prevention
Jannis Heuner
ruhrHUB

Jannis Heuner

Managing Director
ruhrHUB (Germany)
Drug discovery
Mario Huyghe
imec

Mario Huyghe

Senior Venture Development Manager
imec (Belgium)
Virtual care
Drug discovery
Juho Immonen
Bayer

Juho Immonen

Data Scientist
Bayer (Germany)
Drug discovery
prevention
Alper Karagoz
Diffusion Capital Partners (DCP)

Alper Karagoz

Partner
Diffusion Capital Partners (DCP) (Turkiye)
prevention
Bernard Kirsch
Angels Santé

Bernard Kirsch

Angels Santé (France, Metropolitan)
prevention
Lauri Kuronen
LKP-Invest

Lauri Kuronen

CEO, Denmark unit
LKP-Invest (Finland)
Virtual care
Philippa Köhnk
BRYCK

Philippa Köhnk

BRYCK (Germany)
prevention
Nicolas Lagreze
Fusion Partners

Nicolas Lagreze

Head of Venture Building
Fusion Partners (Switzerland)
Virtual care
prevention
Steven Leuridan
Qbic

Steven Leuridan

Partner
Qbic (Belgium)
Virtual care
Drug discovery
prevention
Sebastian Merkel
Digi Health Start

Sebastian Merkel

Junior Professorship for Health and E-Health
Digi Health Start (Germany)
Virtual care
Marco Mohwinckel
Magnolia Health Advisors

Marco Mohwinckel

Tech Tour Advisor
Magnolia Health Advisors (United Kingdom)
Virtual care
prevention
Antonio Murta
Pathena

Antonio Murta

Managing Director
Pathena (Portugal)
prevention
Erki Mölder
Verge Capital Management

Erki Mölder

Managing Partner
Verge Capital Management (Singapore)
Virtual care
prevention
Nicolas Olberg
Twip Impact Ventures

Nicolas Olberg

IT Investor & Managing Director
Twip Impact Ventures (Germany)
Virtual care
Xavier Pardo
Xerpa

Xavier Pardo

Managing Director
Xerpa (Switzerland)
prevention
Johannes Peuling
Bochum Wirtschaftsentwicklung

Johannes Peuling

Head of Agency HealthCampus Bochum
Bochum Wirtschaftsentwicklung (Germany)
Virtual care
Kustaa Piha
Athensmed Oy

Kustaa Piha

CEO and Investor in Healthcare and Medtech
Athensmed Oy (Finland)
Virtual care
prevention
Dietmar Schlößer
TÜV NORD GROUP

Dietmar Schlößer

Director Digitalization & Innovation
TÜV NORD GROUP (Germany)
Virtual care
prevention
Maria Severina
Almaral

Maria Severina

CEO, Angel Investor
Almaral (Finland)
Virtual care
prevention
Remi Spagnol
Supernova Invest

Remi Spagnol

Investments Healthcare
Supernova Invest (France)
Virtual care
Drug discovery
prevention
Christian Stephan
KAIROS - an IQVIA business

Christian Stephan

Managing Director
KAIROS - an IQVIA business (Germany)
prevention
Ralph BMH van Aken
Wolf Nose

Ralph BMH van Aken

CEO & Owner
Wolf Nose (Netherlands)
Virtual care
prevention
James Wilson
Silverpeak

James Wilson

Vice President
Silverpeak (United Kingdom)
Drug discovery